Fournier’s gangrene with dapagliflozin in a rural hospital: a case report

Sodium-glucose cotransporter 2 (SGLT2) inhibitors, which are used for treatment of type 2 diabetes, are associated with risk of urogenital infections. FDA issued a black box warning about multiple case reports of Fournier’s gangrene (FG) observed in patients taking SGLT2 inhibitors. FG is a type of...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbeddini, Ali, Tayefehchamani, Yasamin, Davey, Michelle, Gallinger, Jodi, Hooda, Naushin, Aly, Ahmed, Erickson, Dawn, Lee, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852914/
https://www.ncbi.nlm.nih.gov/pubmed/33526523
http://dx.doi.org/10.1136/bcr-2020-237784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852914/
https://www.ncbi.nlm.nih.gov/pubmed/33526523
http://dx.doi.org/10.1136/bcr-2020-237784

Ejemplares similares